Clinical Trials Browser

Mesothelioma, Malignant × aldesleukin × 90 days × Clear all

NCT07443020 2026-04-07

RIOT 4B

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant